Skip to main content
Signal8

Nally Michael

SEC insider (Form 3/4/5 filer). CIK 0001763945. Director at PPG INDUSTRIES INC (PPG) and 1 other issuer. 21 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in PITTSBURGH, PA.

Companies Nally Michael has filed insider reports for

  • PPG INDUSTRIES INC (PPG): Director
  • Generate Biomedicines, Inc. (GENB): Director, Officer, Chief Executive Officer
Nally Michael profile photo

Nally Michael

CIK: 0001763945

Transaction Breakdown

Open Market Buys (P)1 (4.8%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (19.0%)

Derivative conversions

Awards (A)15 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)1 (4.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PPG INDUSTRIES INC logo
PPG

PPG INDUSTRIES INC

Director
Generate Biomedicines, Inc. logo
GENB

Generate Biomedicines, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (21 total)

  • PPG INDUSTRIES INC logo
    PPG

    PPG INDUSTRIES INC

    Sep 11, 2026
    Award

    Phantom Stock Units

    Direct
    98 shares at avg. $105.50-
  • PPG INDUSTRIES INC logo
    PPG

    PPG INDUSTRIES INC

    Jun 12, 2026
    Award

    Phantom Stock Units

    Direct
    56 shares at avg. $119.34-
  • PPG INDUSTRIES INC logo
    PPG

    PPG INDUSTRIES INC

    Apr 16, 2026
    Award

    Restricted Stock Units

    Direct
    1.7K shares-
  • PPG INDUSTRIES INC logo
    PPG

    PPG INDUSTRIES INC

    Apr 15, 2026
    Exercise

    Phantom Stock Units

    Direct
    1.8K shares at avg. $107.72-
  • PPG INDUSTRIES INC logo
    PPG

    PPG INDUSTRIES INC

    Apr 15, 2026
    Exercise

    Restricted Stock Units

    Direct
    1.8K shares-
  • PPG INDUSTRIES INC logo
    PPG

    PPG INDUSTRIES INC

    Mar 12, 2026
    Award

    Phantom Stock Units

    Direct
    73 shares at avg. $100.73-
  • Generate Biomedicines, Inc. logo
    GENB

    Generate Biomedicines, Inc.

    Mar 4, 2026
    Purchase
    Direct
    20K shares at avg. $12.00$240K
  • Generate Biomedicines, Inc. logo
    GENB

    Generate Biomedicines, Inc.

    Mar 2, 2026
    Conversion
    Indirect
    658.3K shares-
  • Generate Biomedicines, Inc. logo
    GENB

    Generate Biomedicines, Inc.

    Feb 26, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    844.6K shares-
  • Generate Biomedicines, Inc. logo
    GENB

    Generate Biomedicines, Inc.

    Feb 26, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    844.6K shares-

1-10 of 21